Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed: 2020-2024

Historic Return on Capital Employed for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to -0.08%.

  • Eton Pharmaceuticals' Return on Capital Employed rose 32.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.08% for FY2024, which is 2.00% up from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Return on Capital Employed is -0.08%, which was up 22.15% from -0.10% recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Return on Capital Employed ranged from a high of -0.07% in FY2021 and a low of -1.51% during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Return on Capital Employed had a median value of -0.10% in 2023 and averaged -0.20%.
  • In the last 5 years, Eton Pharmaceuticals' Return on Capital Employed soared by 145bps in 2021 and then tumbled by 35bps in 2022.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Return on Capital Employed stood at -1.51% in 2020, then spiked by 145bps to -0.07% in 2021, then tumbled by 35bps to -0.42% in 2022, then surged by 32bps to -0.10% in 2023, then grew by 2bps to -0.08% in 2024.